Relationship Between Social Support and Clinical Outcomes: An Evaluation of Participant-Nominated Treatment Supporters in the HOPE 4 Intervention

Drakos A 1 , McCready T 2 , Lopez-Jaramillo P 3 , Islam S 2 , McKee M 4 , Yusuf S 2 Show all authors , Schwalm JD 2

Affiliations 

  • 1 Faculty of Medicine, University of Ottawa, ON, Canada (A.D.)
  • 2 Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada (A.D., T.M., S.I., S.Y., J.D.S.)
  • 3 Research Institute, Fundación Oftalmológica de Santander, Floridablanca, Colombia (P.L.-J.)
  • 4 Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom (M.M.)
Circ Cardiovasc Qual Outcomes, 2024 Apr;17(4):e009342.
PMID: 38440889 DOI: 10.1161/CIRCOUTCOMES.122.009342

Abstract

BACKGROUND: The HOPE 4 trial (Heart Outcomes Prevention and Evaluation 4) investigated the effectiveness of a comprehensive, collaborative model of care, implemented in Colombia and Malaysia, which aimed to reduce cardiovascular disease risk in individuals with hypertension. One component of this intervention was the nomination of a treatment supporter, where participants could select a family member or friend to assist them with their care. The purpose of this study was to investigate the impact of these individuals on participant outcomes, as well as the relationship dynamics between participants and their treatment supporter.

METHODS: Participants in the HOPE 4 intervention group with baseline and 12 months of follow-up were included for analysis. They were divided into Every Visit (n=339) and

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications